Gilead (GILD) Stock Falls in After-Hours Trading on Q3 Results

NEW YORK (TheStreet) -- Shares of Gilead Sciences  (GILD) were down in after-hours trading on Tuesday after reporting lower-than-expected earnings and sales from hepatitis C treatments for the 2016 third quarter.

After the market close, the Foster City, CA-based biopharmaceutical company reported adjusted earnings of $2.75 per share, missing the FactSet consensus of $2.84 per share. 

Revenue of $7.50 billion topped analysts' expectations of $7.46 billion. 

Revenue from Gilead's hepatitis C treatments Harvoni and Sovaldi came in at $1.86 billion and $825 million, respectively. Analysts surveyed by FactSet were looking for Harvoni sales of $2.32 billion and Sovaldi sales of $1.06 billion.

Separately, TheStreet Ratings team rates the stock as a "buy" with a ratings score of B.

Gilead's strenghts such as its notable return on equity, attractive valuation levels and expanding profit margins outweigh the fact that the company has had sub par growth in net income.

You can view the full analysis from the report here: GILD

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this article's author. 

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%